Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 1/20 | 0.62 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.59 |
| ▸ | LMNA | P02545 | 2/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | ACE | P12821 | 9/20 | 0.48 |
| ▸ | ACE2 | Q9BYF1 | 3/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | REN | P00797 | 3/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | F2 | P00734 | 1/20 | 0.46 |
| ▸ | LTA4H | P09960 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | PEPD | P12955 | 1/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.46 |
| ▸ | HTR2A | P28223 | 1/20 | 0.46 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.46 |
| ▸ | HRH1 | P35367 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL695608 | 1.00 | RAB9A (0.62) | RAB9AL3MBTL1LMNAHSD17B10CYP2C19 | |
| SCHEMBL2634067 | 1.00 | RAB9A (0.62) | RAB9AL3MBTL1LMNAHSD17B10CYP2C19 | |
| SCHEMBL9464451 | 0.98 | RAB9A (0.61) | RAB9AL3MBTL1LMNAHSD17B10CYP2C19 | |
| SCHEMBL18209676 | 0.96 | RAB9A (0.58) | RAB9AL3MBTL1LMNAHSD17B10CYP2C19 | |
| SCHEMBL7815566 | 0.95 | RAB9A (0.57) | RAB9AL3MBTL1LMNAHSD17B10CYP2C19 | |
| SCHEMBL7811720 | 0.95 | RAB9A (0.57) | RAB9AL3MBTL1LMNAHSD17B10CYP2C19 | |
| SCHEMBL16124534 | 0.95 | RAB9A (0.61) | RAB9AL3MBTL1LMNAHSD17B10CYP2C19 | |
| SCHEMBL3710312 | 0.95 | RAB9A (0.57) | RAB9AL3MBTL1LMNAHSD17B10CYP2C19 | |
| SCHEMBL18106053 | 0.94 | RAB9A (0.57) | RAB9AL3MBTL1LMNAHSD17B10CYP2C19 | |
| SCHEMBL7771246 | 0.94 | RAB9A (0.59) | RAB9AL3MBTL1LMNAHSD17B10CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119875045-A | Pyrenyl covalent organic framework material and preparation method and application thereof | 中国石油天然气股份有限公司 | 2025-04-25 | — | — | CN | disclosed |
| CN-107847765-A | The piperidine derivative of 1,4 substitutions | 赛福伦公司 | 2018-03-27 | — | — | CN | disclosed |
| CN-103998429-B | Substituted phenyl amines as CCR (4) antagonist | 凯莫森特里克斯股份有限公司 | 2016-12-07 | — | — | CN | disclosed |
| CN-103998429-A | Substituted anilines as ccr(4) antagonists | CHEMOCENTRYX INC | 2014-08-20 | — | — | CN | disclosed |
| EP-1844022-A1 | QUINAZOLINE DERIVATIVES FOR INHIBITING CANCER CELL GROWTH AND METHOD FOR THE PREPARATION THEREOF | Hanmi Pharm. Co., Ltd. (KR) | 2007-10-17 | — | — | EP | disclosed |
| WO-2006071017-A1 | QUINAZOLINE DERIVATIVES FOR INHIBITING CANCER CELL GROWTH AND METHOD FOR THE PREPARATION THEREOF | HANMI PHARM. CO., LTD. (KR) | 2006-07-06 | — | — | WO | disclosed |
| WO-2006071079-A1 | QUINAZOLINE DERIVATIVES FOR INHIBITING CANCER CELL GROWTH AND METHOD FOR THE PREPARATION THEREOF | HANMI PHARM. CO., LTD. (KR) | 2006-07-06 | — | — | WO | disclosed |
| EP-1087935-A1 | ANTHRACENE DERIVATIVES AS ANTI-CANCER AGENTS | BTG INTERNATIONAL LIMITED (GB) | 2001-04-04 | — | — | EP | disclosed |
| WO-2000001714-A1 | EFFLUX PUMP INHIBITORS | MICROCIDE PHARMACEUTICALS, INC. (US) | 2000-01-13 | — | — | WO | disclosed |
| WO-1999065866-A1 | ANTHRACENE DERIVATIVES AS ANTI-CANCER AGENTS | BTG INTERNATIONAL LIMITED (GB) | 1999-12-23 | — | — | WO | disclosed |